Subscribe
Business

News Summary: Human Genome accepts Glaxo’s deal

By The Associated Press
Published
Add Washington Examiner on Google

ROADBLOCK REMOVED: Human Genome Sciences drops its opposition to being acquired by longtime partner U.K. drugmaker GlaxoSmithKline, thanks to GSK’s higher offer.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.